🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Opportunities for CAR-T Cell Immunotherapy in HIV Cure

Viruses(2023)10.3390/v15030789Source: DataRank Database

Opportunities for CAR-T Cell Immunotherapy in HIV Cure is a research paper published in Viruses (2023). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access29 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 3.38)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Javier Martínez‐Picado ORCID,Talía Velasco-Hernández ORCID,María Salgado ORCID,Gerard Campos-Gonzalez ORCID

Live enrichment

PubMed:36992496 PMC:PMC10057306 OpenAlex:https://openalex.org/W4327953194

Plan Estatal de I + D + I, Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, España

Grant: PRE2021-100501

Plan Estatal de I + D + I, Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, España

Grant: CP22/00038

Plan Estatal de I + D + I, Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, España

Grant: PID2020-115931RA-I00

Plan Estatal de I + D + I, Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, España

Grant: PID2019-109870RB-I00

Plan Estatal de I + D + I, Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, España

Grant: CB21/13/00063

Plan Estatal de I + D + I, Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, España

Grant: 1 UM1 AI164561-01

Plan Estatal de I + D + I, Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, España

Grant: 101057100

The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine

Plan Estatal de I + D + I, Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, España

Grant: 101095606

Impact and viability of a novel mass PCR testing method as a pandemic-fighting strategy

Plan Estatal de I + D + I, Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, España

Grant: 202130-30-31-32

Plan Estatal de I + D + I, Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, España

Grant: PROMETEO/2021/036

Plan Estatal de I + D + I, Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, España

Grant: INVES223069VELA

NIH HHS

Grant: 1 UM1 AI164561-01;

National Institutes of Health

Grant: 5UM1AI164561-03

Reversing Immune Dysfunction for HIV-1 Eradication

FWCI

3.38

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4915/15/3/789/pdf?version=1679482873

publisherhttps://www.mdpi.com/1999-4915/15/3/789/pdf?version=1679482873

publisherhttps://www.mdpi.com/1999-4915/15/3/789/pdf

journalhttps://doi.org/10.3390/v15030789

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36992496

Fields of Study

CAR-T cell therapy researchVirus-based gene therapy researchCRISPR and Genetic EngineeringHumansHIV-1T-LymphocytesReceptors, Chimeric AntigenHIV InfectionsImmunotherapy

MeSH Terms

Receptors, Chimeric AntigenHumansImmunotherapyT-LymphocytesHIV-1HIV Infections

Keywords

Chimeric antigen receptorHuman immunodeficiency virus (HIV)Cell therapyImmunotherapyMedicineImmunologyClinical trialAntiretroviral therapyVirologyCellBiologyImmune systemViral loadInternal medicineHIVHiv ReservoirCar-t CellsLatency Reversal AgentsReceptors, Chimeric AntigenT-LymphocytesHIV InfectionsReviewMicrobiologyQR1-502HIV-1Humans

Sustainable Development Goals

SDG 0: Good health and well-being